Piramal Pharma Rights Issue 2023 Latest News Today

1. ANNOUNCEMENTS ON Piramal Pharma

   June 4, 2024 3:47:00 PM

   Disclosure under Regulation 30 of the SEBI (listing Obligations and DIsclsoure Requirements) Regulations, 2015 - Successful closure of US FDA Inspection of Piramal Pharma ...

   Published by : moneycontrol.com

2. Meet Nandini Piramal, Isha Ambani�s sister-in-law and successful businesswoman; Know about her career, education, and net worth

   June 11, 2024 9:27:00 AM

   Nandini Piramal, Executive Director, Piramal Enterprises and Chairperson of Piramal Pharma Ltd board ... Group�s consolidated revenue for FY 2023 is Rs 9,087 crore. Nandini Piramal continues ...

   Published by : The Financial Express

3. Meet Isha Ambani�s sister-in-law and businesswoman Nandini Piramal

   June 4, 2024 3:30:00 AM

   The Piramal Group heiress is currently the Executive Director of Piramal Enterprises and the Chairperson of Piramal Pharma ... s consolidated revenue for FY 2023 is Rs 9087 crore, according ...

   Published by : GQ

4. Piramal Pharma Ltd (PPLPHARMA) Share Price

   June 21, 2024 3:30:00 AM

   Piramal Pharma Ltd share price was up by 0.86% from ... will go for stock market listing after...' ITR 2023-24: Worried of mistakes while e-filing income tax returns? Consider these tips for ...

   Published by : Business Today

5. Piramal Pharma shares jump over 7% to hit 18-month high, gain 32% in 7 weeks

   May 3, 2024 12:39:00 PM

   Piramal Pharma shares jumped 7.35% in today's trading ... At the current market price, it remains 24% below the issue price. Also Read: Netweb Technologies advanced 147% in just 6 months, up ...

   Published by : MSN

6. Syros Pharmaceuticals: Entering A Decisive Era With An Expected 2024 Phase 3 Readout

   July 2, 2024 8:26:00 PM

   Syros Pharmaceuticals focuses on myeloid cancer therapies with promising pipeline candidate tamibarotene, facing financial challenges. Explore more details here.

   Published by : Seeking Alpha

7. Emcure Pharma gets SEBI nod for public issue

   June 21, 2024 7:38:00 AM

   MUMBAI: Pune-based drug maker Emcure Pharmaceuticals has received ... half of what it originally planned in early 2023. As per market sources, the issue comprises of Rs 800 crore of fresh issue ...

   Published by : The New Indian Express

8. Pharma M&A: The top high value deals in 2023

   June 26, 2024 3:42:00 AM

   Although the pharma industry's dealmaking activity in ... saw somewhat of a resurgence in 2023. While there was a rebound in M&A deals from 2022 to 2023 in terms of total deal values was observed ...

   Published by : Yahoo Finance

9. Pharmaceuticals News

   June 24, 2024 3:30:00 AM

   June 14, 2024 � Researchers have developed a new nanomedicine therapy that delivers anticancer drugs to lung cancer cells and enhances the immune system's ability to fight cancer. The team ...

   Published by : Science Daily

10. Riley Gaines: Trans athletes make women�s sports a civil rights issue

    June 2, 2024 5:37:00 PM

    It�s the preeminent civil rights issue of our day: the protection of girls in women�s sports. Last month�s stolen victory by a male runner in the girls� 400-meter dash at the Washington ...

    Published by : New York Post

11. Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98%

    June 24, 2024 12:26:00 PM

    STOCKHOLM, June 24, 2024 /PRNewswire/ -- ("Moberg Pharma" or the "Company") announces that 17,776,856 warrants of series ... before issue costs. "When we designed the oversubscribed rights issue ...

    Published by : Morningstar

Read Piramal Pharma Rights Issue 2023 current news. Find Piramal Pharma Rights Issue 2023 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Piramal Pharma Limited Rights Issue grey market premium and Piramal Pharma Rights Issue 2023 expected listing price.

Read more about Piramal Pharma Rights Issue 2023

• Piramal Pharma Rights Issue 2023 Detail
• Piramal Pharma Rights Issue 2023 Review
• Piramal Pharma Rights Issue 2023 FAQ's
• Piramal Pharma Rights Issue 2023 Live News
• Piramal Pharma Rights Issue 2023 Rights Issue Calendar Events